BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30670687)

  • 21. Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria.
    Fernández-Becerra C; Pinazo MJ; González A; Alonso PL; del Portillo HA; Gascón J
    Malar J; 2009 Apr; 8():55. PubMed ID: 19341456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does the brief treatment with antimalarials favorably influence drug resistance and recurrences?].
    Kroeger A
    Rev Panam Salud Publica; 2001 Mar; 9(3):202-4. PubMed ID: 11349355
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed gametocyte clearance in
    Salazar YEAR; Louzada J; Puça MCSdB; Guimarães LFF; Vieira JLF; Siqueira AMd; Gil JP; Brito CFAd; Sousa TNd
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0120423. PubMed ID: 38411047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone Marrow Is a Major Parasite Reservoir in Plasmodium vivax Infection.
    Obaldia N; Meibalan E; Sa JM; Ma S; Clark MA; Mejia P; Moraes Barros RR; Otero W; Ferreira MU; Mitchell JR; Milner DA; Huttenhower C; Wirth DF; Duraisingh MT; Wellems TE; Marti M
    mBio; 2018 May; 9(3):. PubMed ID: 29739900
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
    Hailemeskel E; Menberu T; Shumie G; Behaksra S; Chali W; Keffale M; Belachew M; Shitaye G; Mohammed H; Abebe D; Ashine T; Drakeley C; Mamo H; Petros B; Bousema T; Tadesse FG; Gadisa E
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():8-12. PubMed ID: 31539706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia.
    Sutanto I; Endawati D; Ling LH; Laihad F; Setiabudy R; Baird JK
    Malar J; 2010 Feb; 9():52. PubMed ID: 20152016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
    Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV
    Malar J; 2013 Sep; 12():310. PubMed ID: 24007534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survey of in vivo sensitivity to chloroquine by Plasmodium falciparum and P. vivax in Lombok, Indonesia.
    Fryauff DJ; Baird JK; Candradikusuma D; Masbar S; Sutamihardja MA; Leksana B; Tuti S; Marwoto H; Richie T; Romzan A
    Am J Trop Med Hyg; 1997 Feb; 56(2):241-4. PubMed ID: 9080887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.
    Lek-Uthai U; Suwanarusk R; Ruengweerayut R; Skinner-Adams TS; Nosten F; Gardiner DL; Boonma P; Piera KA; Andrews KT; Machunter B; McCarthy JS; Anstey NM; Price RN; Russell B
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2435-41. PubMed ID: 18443130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
    Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G
    Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.
    Shalini S; Chaudhuri S; Sutton PL; Mishra N; Srivastava N; David JK; Ravindran KJ; Carlton JM; Eapen A
    Malar J; 2014 Mar; 13():129. PubMed ID: 24685286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
    Mula P; Fernández-Martínez A; de Lucio A; Ramos JM; Reyes F; González V; Benito A; Berzosa P
    Malar J; 2011 Aug; 10():214. PubMed ID: 21810256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria historians: analyze your old slides!
    Sibley CH
    Trends Parasitol; 2006 Jun; 22(6):243-4. PubMed ID: 16632405
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan.
    Khatoon L; Baliraine FN; Bonizzoni M; Malik SA; Yan G
    Am J Trop Med Hyg; 2009 Sep; 81(3):525-8. PubMed ID: 19706926
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    McCallum FJ; Birrell GW; Chavchich M; Harris I; Obaldia N; Van Breda K; Heffernan GD; Jacobus DP; Shanks D; Edstein MD
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic responses of Plasmodium vivax and P. falciparum to chloroquine, in an area of western India where P. vivax predominates.
    Srivastava HC; Yadav RS; Joshi H; Valecha N; Mallick PK; Prajapati SK; Dash AP
    Ann Trop Med Parasitol; 2008 Sep; 102(6):471-80. PubMed ID: 18782486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.
    Mishra N; Srivastava B; Bharti RS; Rana R; Kaitholia K; Anvikar AR; Das MK; Ghosh SK; Bhatt RM; Tyagi PK; Dev V; Phookan S; Wattal SL; Sonal GS; Dhariwal AC; Valecha N
    J Vector Borne Dis; 2016; 53(2):168-78. PubMed ID: 27353588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and biochemical aspects of drug resistance in malaria parasites.
    Hayton K; Su XZ
    Curr Drug Targets Infect Disord; 2004 Mar; 4(1):1-10. PubMed ID: 15032630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria?
    Mason DP; Krudsood S; Wilairatana P; Viriyavejakul P; Silachamroon U; Chokejindachai W; Singhasivanon P; Supavej S; McKenzie FE; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):57-63. PubMed ID: 11485096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.